Assertio Therapeutics's market cap is currently ―. The company's EPS TTM is $1.754; its P/E ratio is 3.65; Assertio Therapeutics is scheduled to report earnings on May 4, 2023, and the estimated EPS forecast is $0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 50.35M	$ 34.21M	$ 35.13M	$ 36.54M	$ 33.33M
Gross Profit	$ 44.34M	$ 30.20M	$ 30.60M	$ 32.34M	$ 28.43M
EBIT	$ 9.78M	$ 6.36M	$ 10.70M	$ 12.10M	$ 7.48M
EBITDA	$ 18.15M	$ 14.48M	$ 18.91M	$ 20.80M	$ 14.86M
Net Income Common Stockholders	$ 88.55M	$ 4.17M	$ 7.83M	$ 9.06M	$ 4.61M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 64.94M	$ 64.83M	$ 52.26M	$ 61.39M	$ 36.81M
Total Assets	$ 413.91M	$ 323.34M	$ 321.98M	$ 339.13M	$ 326.55M
Total Debt	$ 66.87M	$ 68.16M	$ 61.16M	$ 73.52M	$ 73.49M
Net Debt	$ 1.93M	$ 3.33M	$ 8.90M	$ 12.13M	$ 36.68M
Total Liabilities	$ 188.19M	$ 188.43M	$ 193.61M	$ 227.27M	$ 224.13M
Stockholders Equity	$ 225.72M	$ 134.91M	$ 128.37M	$ 111.86M	$ 102.41M
Cash Flow	-
Free Cash Flow	$ 26.42M	$ 10.04M	$ 14.43M	$ 27.43M	$ 4.08M
Operating Cash Flow	$ 26.70M	$ 10.04M	$ 14.43M	$ 27.43M	$ 4.13M
Investing Cash Flow	$ -25.78M	$ -371.00K	$ -16.11M	$ -404.00K	$ -18.52M
Financing Cash Flow	$ -798.00K	$ 2.89M	$ -7.44M	$ -2.44M	$ -7.52M

Currency in USD

Assertio Therapeutics Earnings and Revenue History

Income Statement >

Assertio Therapeutics Debt to Assets

Balance Sheet >

Assertio Therapeutics Cash Flow

Cash Flow >

Assertio Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing